WHO WE ARE

Rijuven, founded in 2012 by Raj Kapoor, MD, FCCP and Evens Augustin, MBA,  was created to commercialize medical devices that have a world impact. Together with numerous contributors and partners, Rijuven’s mission is to make healthcare affordable and accessible at the times and places it matters most.

We are a team of clinicians, technologists, designers, innovation strategist, patients and consumers that have come together to create compelling products. Rijuven has set out  to transform global medical device markets and revolutionize care delivery through the use of select innovations that increase outcomes, drive down costs and expand care access.  Leadership Team

 

 

 

NEWS & EVENTS

In October, Rijuven unveiled CardioSleeve for Pediatrics and Newbie Care at the American Academy of Pediatrics 2015 convention. The event solidified Rijuven’s commitment and continued industry support for revolutionizing the connection between humans and health.

Visit Rijuven's booth at the American Telemedicine Association.  The American Telemedicine Association is the leading international resource and advocate promoting the use of advanced remote medical technologies.  At the 2015 conference, we will be demonstrating our telehealth technologies.

   

 

 

OUR MISSION

We are dedicated innovators that are determined to solve the problems impacting world health.  We synthesize cutting edge technology, medical expertise and a superior patient experience into products that better the lives we touch and make healthcare portable. Healthcare’s future drives the quality standard to which we keep.  We are a seed of health innovation.

RIJUVEN INNOVATION

 

At Rijuven, we believe that innovative medical devices require a core value of design, utility and function.

Design- Our medical devices are designed to be simple to use, at any point of care. We design devices that are mobile, fit in the palm of the hand, are lightweight and elegant.

Utility- Our medical devices have to be useful to anyone, anywhere. They must be built with clinician, patient and point of care in mind. Our innovations are built to impact all of humanity, from preventive medicine to emergency situations; in healthcare facilities and homes; for medical professionals to help patients around the world in any environment.

Function- Our medical devices must function consistently and confidently well, while adding features and diagnostic values that are efficacious in result. Our devices must save medical professionals time, increase outcomes, and lower healthcare costs. The integration of leading edge technologies is required to maximize the functionality of every device we create.

A NOTE FROM THE PRESIDENT

Before the 19th century, physicians could listen to the heart only by applying their ear directly to the chest. This primitive method had social and technical limitations and fell out of favor. With the invention of the stethoscope (from Greek stéthos - chest and skopé - examination) by Laennec in 1816, mediate auscultation became possible, introducing an exciting and practical new method of bedside examination.

Over the past 2 centuries, many illustrious physicians have contributed to the understanding of cardiac auscultation by providing an explanation for the sounds and murmurs that are heard in the normal and diseased heart.

Auscultation remains a low cost, but still sophisticated procedure that intimately connects the physician to the patient and transfers that all-important clinical power known as the laying on of the hands.

At Rijuven we believe that the stethoscope deserves our continued respect and more attention as an indispensable aid for the evaluation of patients.

Our CardioSleeve is a unique stethoscope accessory device for acquiring the acoustic and electrical footprints of the heart, with results being displayed on embedded and mobile devices, and decision support software to record and analyze acoustic heart signals. It greatly reduces health care cost due to a more accurate and timely diagnosis and provides objective; repeatable findings that are easily archived and retrieved as electronic medical record.

We continue to challenge the present. There is no finish line. There is always a new barrier to break, and even greater excellence and innovation to serve humanity at large.

-Raj Kapoor, MD, FCCP
 

LEADERSHIP TEAM

 

Raj Kapoor, MD, FCCP– President and Co-Founder

 

A Pulmonary/Critical Care specialist by training, Dr. Kapoor is also Board Certified in Sleep Medicine. He is a Fellow American College of Chest Physicians and a Member of the American Academy of Sleep Medicine. He is the Former Chair Department of Medicine, UPMC Passavant and currently serving as the Medical Director of Epoch Sleep Disorders Center and Restful Night Sleep Center, Pennsylvania.

 

Evens Augustin – CEO and Co-Founder

 

He holds a BS in Mechanical & Biomedical Engineering from Carnegie Mellon University and an MBA from the University of Pittsburgh.

An entrepreneur with a practical interest in technology businesses, he co-founded a consumer health and wellness company offering better living through better sleep.  He has a comprehensive background in the areas of E-commerce, Finance, Supply Chain Management, transaction security, and content distribution.

 

Justin Bass- Chief Strategist

 

Mr. Bass holds a BS degree from Carnegie Mellon University in Business Administration with a concentration in Graphic Media Management.

Justin Bass provides Health Innovation Strategy to include startup management, strategic marketing, product development and policy.   As the Managing Director of Like Minded Strategy Group, and a serial entrepreneur, Justin has held various strategic consulting roles in early stage healthcare ventures that include clinical organizational development, clinical risk management, health IT, product development, technology commercialization and innovation. 

 

Lucius Polk- Chief Marketing Officer

 

Lucius Polk received degrees in both Economics and Sociology from the University of Notre Dame where he was also a four year athlete on the lacrosse team. Mr. Polk manages sales and marketing efforts for Rijuven as well as leading the consumer products division. After a short lived professional lacrosse career, Lucius has worked extensively with early growth ventures in consumer health and wellness, specializing in brand positioning, sales and distribution, fulfillment/supply chain, and product development.

As a Washington, DC native, Lucius is passionate about solving national health issues with thoughtful patient empowering health innovation.

 

Taras Silecky- Chief Business Development Officer

 

Taras Mr. Silecky brings deep experience in healthcare and technology as an executive and VC. Prior to Rijuven, Mr. Silecky served in operating roles with M*Modal, Inc., Follett Higher Education Group and Bio-Logic Systems. Mr. Silecky led and managed investments for Ascension Health Ventures and Western NIS Enterprise Fund. Mr. Silecky earned his MS in Computer Science from DePaul University and BS in Bio-Medical Engineering from Northwestern University.

 

ADVISORY BOARD

 

Bernard Harris, Jr. M.D., M.B.A., F.A.C.P.

 

Dr. Harris is the Past President of the American Telemedicine Association for the 2011-2012 term.

Dr. Harris is currently Chief Executive Officer and Managing Partner of Vesalius Ventures, a venture capital firm, that invests in early to mid stage Healthcare technologies and companies. Prior to Vesalius Ventures, he was at NASA, a veteran astronaut for over eighteen years, he has logged more than 438 hours and traveled over 7.2 million miles in space.

Currently, he is on the Board for the Houston Angel Network, Houston Technology Center and BioHouston. He is a member of the Board of Directors for Monebo Technologies, RMD Networks, U.S. Physical Therapy (Nasdaq: USPH), Sterling Bancshares (Nasdaq: SBIB), and the Space Agency. Dr. Harris is also the founder and president of the Harris Foundation, which supports math and science education and crime prevention programs for America’s youth.

He is the recipient of numerous awards, including honorary doctorates from Stony Brook University (SUNY), Morehouse School of Medicine, and University of Hartford, NASA Space Flight Medal, NASA Award of Merit, a fellow of the American College of Physicians, and was the recipient of the 2000 Horatio Alger Award.

 

Joon Sup Lee, MD

 

Dr. Lee serves as the Co-Director of the UPMC Heart and Vascular Institute, Chief in the Division of Cardiology at the University of Pittsburgh School of Medicine, and Associate Professor in the Department of Medicine at the University of Pittsburgh.

An interventional cardiologist by training, Dr. Lee’s research and clinical interests include the role of stem cells in the treatment of coronary artery disease. He also was instrumental in the implementation of “door-to-balloon time” at UPMC – a protocol that streamlines the triage process of heart attack patients arriving in emergency department.

Dr. Lee earned his medical degree from Duke University School of Medicine in Durham, NC. He then completed a medical internship and residency, as well as two cardiology fellowships, at Massachusetts General Hospital in Boston. He joined the University of Pittsburgh faculty in 1996 after serving as an instructor in medicine at Harvard Medical School.

A member of the American Heart Association (AHA), Dr. Lee was appointed president-elect of the AHA’s Allegheny Division. He is a member of the American College of Physicians and the Massachusetts Medical Society, and has been appointed to fellowship in the American College of Cardiology. 

Dr. Lee is the author or co-author of nearly 15 professional articles and 20 abstracts.

 

Neil Niren, MD

 

A Dermatologist by training, Dr Niren has over 40 years’ experience in teaching and consulting practice. He is a Fellow of the American Society for Mohs Surgery and a member of Pennsylvania Academy of Dermatology, American Academy of Dermatology and International Society of Dermatologic Surgery.

His research at Johns Hopkins University and NIH from 1971- 1974 include Atherosclerosis, Skin Cancer, Steroid synthesis, Antibiotic synthesis and Delayed Bioluminescence. He has several publications to his credit and has served on the Advisory Board as a Medical Consultant for several pharmaceutical companies.

 

Dale J. Misczynski

 

Mr. Misczynski is the President and CEO of Monebo. Dale has a strong background in the global electronics business, having spent over thirty-four years at positions of increasing responsibility at Motorola. His experiences as a successful leader in Motorola’s wireless communications and semiconductor businesses, operating in marketing, engineering, quality, and general management roles at division and group levels have given him the global perspective needed to lead Monebo.

 

Richard Maenza, MD

 

Dr. Richard Maenza is Board Certified by the American Board of Emergency Medicine. He is currently a Partner in Emergency Medicine Physicians (EMP), based in Canton, OH. This single-specialty group practice employs over 650 Emergency Physicians and 300 Advance Practice Providers, staffing over 60 Emergency Departments nationwide.

Dr Maenza was the CEO and Founding Partner of RhythmWatch, LLC, an ambulatory cardiac monitoring service based in Pittsburgh, PA from 2003 to 2012. He maintains an interest in entrepreneurial medicine, currently staffing StatDoctors, a telemedicine service which is among the first in the industry to offer live, on-demand mobile eVisits.